Welcome to our Knowledge Hub

Cell and Gene Therapies (CGT) represent a groundbreaking advancement in modern medicine, offering curative potential for genetic disorders, cancer, and degenerative diseases. These therapies utilize engineered cells or genetic modifications to treat or replace damaged tissues and defective genes. All approaches demand highly controlled manufacturing processes to ensure safety, efficacy, and scalability.

Advanced therapies like cell-based therapies have emerged as a promising field in regenerative medicine, offering novel treatment approaches for conditions such as cancer, autoimmune diseases, and degenerative disorders. One critical distinction in these therapies is whether the cells come from the patient themselves (autologous) or from a donor (allogeneic). Both approaches have unique benefits and limitations, impacting their clinical application and scalability.

iPSCs and MSCs are transforming regenerative medicine by curing diseases once considered untreatable.

What makes a good adherent cell expansion system for cell and gene therapy? There is a great need for adherent cell expansion systems...

Aren't suspension systems good enough? Adherent cells are the backbone of recent biotechnology innovations that work towards a...

The bioprocessing industry’s manufacturing capacity crunch Imagine a world where chronic diseases such as heart diseases, cancers, or...